MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617072558 A) filed by Glaxosmithkline Intellectual Property on June 11, 2026, for Il-33 Binding Antibodies.
Inventors include Orecchia, Martin; Edwards, Matthew; Beaton, Andrew Number; Hook, Laura; Dixon, David; Guo, Xieyang; and Chung, Chun-Wa.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present disclosure relates to the treatment of interleukin 33 (IL-33) mediated diseases, including lung diseases. In particular, the present disclosure relates to IL-33 binding proteins, including anti-IL-33 antibodies, and their uses in the treatment of IL-33 mediated diseases.
Disclaimer: Curated by HT Syndication.
